← Evidence map

ArticleExperimental and therapeutic medicine2017

Members of the microRNA-200 family are promising therapeutic targets in cancer.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28672887